CF
ONC

Corebridge Financial’s BeOne Medicines Ltd ONC Stock Holding History

Corebridge Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-700
Closed -$99.9K – 3050
2024
Q2 		$99.9K Buy
+700
New +$108K ﹤0.01% 2604

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Corebridge Financial's ONC Position: Q3 2024 in Review

Corebridge Financial sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 700 shares — an estimated $99.9K sold.

Corebridge Financial first reported a position in ONC in Q2 2024 and held it in 1 quarter. The position peaked at $99.9K in Q2 2024. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Corebridge Financial reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Corebridge Financial sold 700 BeOne Medicines Ltd shares in Q3 2024, an estimated $99.9K.
  • Corebridge Financial first reported a position in BeOne Medicines Ltd in Q2 2024 and held it in 1 quarter.
  • Corebridge Financial's BeOne Medicines Ltd position peaked at $99.9K in Q2 2024.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.